Om. Fuskevag et al., Microvascular perturbations in rats receiving the maximum tolerated dose of methotrexate or its major metabolite 7-hydroxymethotrexate, ULTRA PATH, 24(5), 2000, pp. 325-332
Methotrexate (MTX) is a clinically important cytostatic antifolate. The stu
dy describes the acute effects of maximum tolerated doses of MTX or its maj
or metabolite 7-hydroxymethotrexate (7-OH-MTX) on the ultrastructure of rat
liver and kidneys. The ultrastructural changes in rats receiving MTX or 7-
OH-MTX were, in principle, indistinguishable and their severity and extensi
on increased with time of survival or doses of medication. All lesions were
focal, microvascular, or parenchymal. Microvascular changes were more seve
re in nature when blood cells were present. The endothelial cells were swol
len with loss of pinocytotic vesicles, their luminal plasma membrane formed
blebs or were disrupted. Partly detached endothelial cells or deendothelia
lized areas, various types of white blood cells, in particular, neutrophil
granulocytes, were observed in the microcirculation. Single platelets or sm
all platelet aggregates were found either in the lumen or adhering to deend
othelialized areas of injured endothelial cells. Hepatocytes exhibited stea
tosis, edema, and manifest single cell necrosis. There were also nuclear ch
anges, marked proliferation of smooth endoplasmatic reticulum, increased am
ounts of intracellular lipid vacuoles, and a decrease in glycogen particles
in hepatocytes. The kidney presented the major changes in the tubules and
in the interstitial part. MTX and 7-OH-MTX acute toxicity may primarily be
related to microvascular perturbation.